FDA records linked by MedtechLedger identify Globus Medical, Inc. at 2560 General Armistead Ave., Audubon, Pennsylvania, as the applicant for K262779, the ANTHEM™ Fracture System. The filing was received August 5, 2026, and decided October 23, 2026, as Substantially Equivalent. The device carries product code HRS, with HWC listed as a subsequent product code, and is classified under 21 CFR 888.3030 as a single/multiple component metallic bone fixation appliance and accessory in Class II. The review panel and medical specialty are both orthopedic, the clearance type is Traditional, and the record states the device was not reviewed by a third party. The FDA decision letter describes the subject device as substantially equivalent to the predicate devices with respect to technical characteristics, performance and intended use. [1][2][3]
The documented filing and its scope
K262779 covers the ANTHEM™ Fracture System under product code HRS, with HWC as a subsequent product code, and regulation number 888.3030. The FDA record lists the device classification name as Plate, Fixation, Bone, the advisory committee as orthopedic, and the decision as Substantially Equivalent (SESE). The filing is a Traditional 510(k), is not a combination product, and has no authorized predetermined change control plan. The decision letter is addressed to Amber Thomas, Regulatory Specialist, at the Audubon address, and the applicant contact in the FDA database is the same individual. [1][2][3]
The FDA decision letter states that the subject ANTHEM™ Fracture System was found substantially equivalent to the predicate devices with respect to technical characteristics, performance and intended use, and that the information provided supports substantial equivalence. The letter also references a review of concerns of safety or effectiveness for the intended use. The filing record notes that a summary is available as the statement or summary type. [2]
ANTHEM product family in manufacturer documentation
Globus Medical’s published surgical technique guides describe ANTHEM systems for specific anatomical applications: the Clavicle Fracture System, the Ankle Fracture System, the Proximal Humerus Fracture System, the Distal Radius Fracture System, the Mini Fragment Fracture System and the Distal Femur Fracture System. Each guide presents the technique as illustrative and states that the technique actually employed depends on the surgeon’s medical judgment before and during surgery. The guides direct readers to package inserts or system instructions for use for description, indications, contraindications, warnings and precautions. [4][5][6][7][8][9]
The Ankle Fracture System guide includes a section referencing CAPTIVATE™ compression screws. The Mini Fragment guide states that implants may be available sterile or nonsterile and that instruments are available nonsterile, and it notes that federal law restricts the device to sale by or on the order of a physician. These are manufacturer statements about product configuration and labeling, not FDA determinations in K262779. [5][8]
Applicant identity and corporate attribution
The FDA records name Globus Medical, Inc. as the applicant and correspondent for K262779, with the Audubon, Pennsylvania, address given as the filing address. That address appears in the FDA database and decision letter as correspondence information; the records do not establish it as a corporate headquarters. The manufacturer’s guides carry Globus Medical branding, an address in Audubon, customer service telephone and fax numbers, and references to globusmedical.com and its patents page. [1][2][3][5][6]
The guides identify “Life moves us” as a registered trademark of Globus Medical and state a mission to deliver technology, research and solutions intended to promote healing in patients with musculoskeletal disorders. No parent company, ownership structure or brand hierarchy is verified in these records, so none is asserted here. [4][5][6]
What the collection shows and does not show
As of November 20, 2026, the linked collection contains one 510(k) record, K262779, and its decision count is one Substantially Equivalent decision. The explicitly smaller record sample contains the same single entry, so the sample decision count is also one. These figures describe the linked filings at that date and are not measures of total company sales, total portfolio or safety performance. [1][3]
No recall records are included in the collection. The records do not report clinical outcome data, commercial availability, certifications or customer relationships for the ANTHEM™ Fracture System, and no such claims are made here. [1][2]






